Market Closed -
Nyse
04:00:02 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
212.3
USD
|
+1.38%
|
|
+1.79%
|
-15.61%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,735
|
6,354
|
10,734
|
8,449
|
9,709
|
8,229
|
-
|
-
|
Enterprise Value (EV)
1 |
5,735
|
6,354
|
10,734
|
8,287
|
9,567
|
7,940
|
7,864
|
7,650
|
P/E ratio
|
123
x
|
-398
x
|
2,052
x
|
-4,449
x
|
108
x
|
77.2
x
|
56
x
|
42.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.5
x
|
11.3
x
|
14.4
x
|
9.97
x
|
9.17
x
|
6.62
x
|
5.7
x
|
4.94
x
|
EV / Revenue
|
10.5
x
|
11.3
x
|
14.4
x
|
9.78
x
|
9.04
x
|
6.39
x
|
5.44
x
|
4.59
x
|
EV / EBITDA
|
103
x
|
410
x
|
209
x
|
214
x
|
74.4
x
|
46.5
x
|
34
x
|
25.6
x
|
EV / FCF
|
1,262
x
|
-110
x
|
-919
x
|
-111
x
|
116
x
|
68.8
x
|
49.6
x
|
41.8
x
|
FCF Yield
|
0.08%
|
-0.91%
|
-0.11%
|
-0.9%
|
0.86%
|
1.45%
|
2.02%
|
2.39%
|
Price to Book
|
11.8
x
|
9.93
x
|
11.3
x
|
8.49
x
|
8.25
x
|
6.5
x
|
5.56
x
|
4.4
x
|
Nbr of stocks (in thousands)
|
34,914
|
36,311
|
37,359
|
37,979
|
38,596
|
38,765
|
-
|
-
|
Reference price
2 |
164.3
|
175.0
|
287.3
|
222.5
|
251.5
|
212.3
|
212.3
|
212.3
|
Announcement Date
|
2/25/20
|
2/23/21
|
2/22/22
|
2/23/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
547.4
|
560.4
|
747.6
|
847.1
|
1,059
|
1,242
|
1,445
|
1,666
|
EBITDA
1 |
55.61
|
15.49
|
51.45
|
38.73
|
128.5
|
170.6
|
231
|
299.2
|
EBIT
1 |
47.51
|
2.595
|
35.04
|
14.41
|
101.3
|
139.8
|
191.1
|
259.9
|
Operating Margin
|
8.68%
|
0.46%
|
4.69%
|
1.7%
|
9.57%
|
11.25%
|
13.23%
|
15.6%
|
Earnings before Tax (EBT)
1 |
50.14
|
-
|
-10.5
|
3.892
|
79.65
|
138.4
|
189.4
|
256
|
Net income
1 |
48.46
|
-15.7
|
5.284
|
-2.002
|
90.95
|
107.5
|
150.7
|
204.6
|
Net margin
|
8.85%
|
-2.8%
|
0.71%
|
-0.24%
|
8.59%
|
8.65%
|
10.43%
|
12.28%
|
EPS
2 |
1.340
|
-0.4400
|
0.1400
|
-0.0500
|
2.320
|
2.749
|
3.788
|
5.031
|
Free Cash Flow
1 |
4.543
|
-58
|
-11.68
|
-74.96
|
82.12
|
115.4
|
158.7
|
183
|
FCF margin
|
0.83%
|
-10.35%
|
-1.56%
|
-8.85%
|
7.76%
|
9.29%
|
10.99%
|
10.99%
|
FCF Conversion (EBITDA)
|
8.17%
|
-
|
-
|
-
|
63.89%
|
67.65%
|
68.71%
|
61.17%
|
FCF Conversion (Net income)
|
9.38%
|
-
|
-
|
-
|
90.29%
|
107.39%
|
105.32%
|
89.45%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/25/20
|
2/23/21
|
2/22/22
|
2/23/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
204
|
203.9
|
208.3
|
213.7
|
221.2
|
241.4
|
261.5
|
270.9
|
284.7
|
278.7
|
297.6
|
321
|
343.1
|
325.3
|
346.6
|
EBITDA
1 |
8.241
|
3.465
|
5.79
|
14.04
|
13.65
|
16.96
|
26.98
|
40.15
|
44.45
|
26.82
|
35.92
|
51.55
|
58.64
|
40.87
|
47.11
|
EBIT
1 |
2.488
|
-2.261
|
1.646
|
7.814
|
7.213
|
10.39
|
20.27
|
33.22
|
37.41
|
19.3
|
27.39
|
43.42
|
50.69
|
34.97
|
41.83
|
Operating Margin
|
1.22%
|
-1.11%
|
0.79%
|
3.66%
|
3.26%
|
4.3%
|
7.75%
|
12.26%
|
13.14%
|
6.93%
|
9.2%
|
13.53%
|
14.77%
|
10.75%
|
12.07%
|
Earnings before Tax (EBT)
1 |
-40.95
|
-5.104
|
-1.167
|
3.035
|
7.128
|
8.652
|
19.54
|
13.3
|
38.16
|
14.63
|
26.81
|
43.02
|
50.77
|
35.82
|
42.03
|
Net income
1 |
-24.63
|
0.079
|
-3.687
|
-2.271
|
3.877
|
8.562
|
18.96
|
9.214
|
54.22
|
11
|
20.98
|
33.65
|
39.79
|
29.44
|
34.55
|
Net margin
|
-12.07%
|
0.04%
|
-1.77%
|
-1.06%
|
1.75%
|
3.55%
|
7.25%
|
3.4%
|
19.05%
|
3.95%
|
7.05%
|
10.48%
|
11.6%
|
9.05%
|
9.97%
|
EPS
2 |
-0.6600
|
-
|
-0.1000
|
-0.0600
|
0.1000
|
0.2200
|
0.4800
|
0.2300
|
1.380
|
0.2800
|
0.5373
|
0.8644
|
1.021
|
0.7433
|
0.8704
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/22/22
|
5/3/22
|
8/4/22
|
11/3/22
|
2/23/23
|
5/2/23
|
8/1/23
|
11/2/23
|
2/22/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
161
|
142
|
289
|
365
|
579
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
4.54
|
-58
|
-11.7
|
-75
|
82.1
|
115
|
159
|
183
|
ROE (net income / shareholders' equity)
|
7.84%
|
0.71%
|
3.3%
|
0.65%
|
7.52%
|
8.59%
|
10.1%
|
12%
|
ROA (Net income/ Total Assets)
|
6.03%
|
0.54%
|
2.55%
|
0.49%
|
5.59%
|
6.79%
|
8.03%
|
9.36%
|
Assets
1 |
804
|
-2,929
|
207.5
|
-410.2
|
1,627
|
1,583
|
1,877
|
2,186
|
Book Value Per Share
2 |
13.90
|
17.60
|
25.40
|
26.20
|
30.50
|
32.60
|
38.20
|
48.30
|
Cash Flow per Share
2 |
0.7300
|
-0.9300
|
-
|
-1.470
|
2.480
|
3.260
|
4.290
|
5.750
|
Capex
1 |
22.1
|
24.8
|
21.2
|
19.3
|
15.2
|
17.5
|
19.3
|
13.1
|
Capex / Sales
|
4.04%
|
4.42%
|
2.83%
|
2.28%
|
1.44%
|
1.41%
|
1.34%
|
0.78%
|
Announcement Date
|
2/25/20
|
2/23/21
|
2/22/22
|
2/23/23
|
2/22/24
|
-
|
-
|
-
|
Last Close Price
212.3
USD Average target price
269.2
USD Spread / Average Target +26.79% Consensus |
1st Jan change
|
Capi.
|
---|
| -15.61% | 8.23B | | +73.46% | 12.41B | | +3.88% | 6.46B | | +14.69% | 5.5B | | -5.53% | 5.33B | | +42.58% | 5.1B | | -32.61% | 2.54B | | +10.80% | 1.99B | | -0.74% | 1.99B | | +10.31% | 1.77B |
Medical Equipment
|